DKMS Panel Discussion

October 11, 2022
All day
Panel Discussion
DKMS Panel Discussion

On Tuesday, October 11, 2022, a panel discussion on the topic of “blood cancer” will take place at the UMFST-UMCH Campus in Hamburg – in cooperation with DKMS. In the course of the event, there will also be the opportunity for our students to register as stem cell donors.

As a special guest, UMFST-UMCH student Moritz Graf will participate in the panel discussion. He has been diagnosed with blood cancer twice at a young age and will speak at the event about his illness, treatment and recovery process, his donation experience as well as the many emotions associated with it. In addition, Sydney Anyanwu, an actual donor, will be in attendance to share the perspective of someone whose donation helped save a life. The panel discussion will be hosted by UMFST-UMCH students Baraneh Salamat (2nd year) and Ivan Bergo (3rd year).

All participating students will be given the opportunity to receive a registration kit on the evening of the event – or from October 12, 2022 also at the helpdesk. The registration kit must be returned to the DKMS collection box at the helpdesk by October 19, 2022.

DKMS (German Bone Marrow Donor File) is an international non-profit organization dedicated to the fight against blood cancer. It was founded in 1991 and, with more than 1,000 employees worldwide, pursues the goal of giving as many people as possible a second chance at life. Thanks to more than 11,000,000 donors, DKMS has succeeded in doing so more than 100,000 times. This makes it the world’ s leading organization in the supply of stem cell transplants to patients. In addition to Germany, the organization is active in the USA and the United Kingdom, as well as in Chile and South Africa. In India, it has also founded the DKMS-BMST joint venture together with the Bangalore Medical Services Trust. In addition, DKMS is involved in the field of medicine and science with its own research unit in order to continually improve patients’ chances of survival and recovery. In its high-performance laboratory, the DKMS Life Science Lab, it sets global standards in the typification of potential stem cell donors.